Elite in Acute Promyelocytic Leukemia

Eduardo M. Rego

Av. Prof. Lineu Prestes, 1524, 
Sao Paulo, SP, BR 
Elite in Acute Promyelocytic Leukemia
Av. Prof. Lineu Prestes, 1524, 
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Eduardo Rego practices in Sao Paulo, Brazil. Mr. Rego and is rated as an Elite expert by MediFind in the treatment of Acute Promyelocytic Leukemia. His top areas of expertise are Acute Promyelocytic Leukemia, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Transplant, and Splenectomy.

His clinical research consists of co-authoring 164 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 49 articles in the study of Acute Promyelocytic Leukemia.

Gender
Male

Locations

Av. Prof. Lineu Prestes, 1524, Sao Paulo, SP 05508900, Brazil
Other Locations
Ribeirao Preto, SP, Brazil
Rio De Janeiro, RJ, Brazil
Paulo, MA, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia: A Randomized, Controlled, 2x2 Factorial Study
Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia: A Randomized, Controlled, 2x2 Factorial Study
Enrollment Status: Withdrawn
Publish Date: August 11, 2021
Intervention Type: Drug
Study Drugs: Methylprednisolone, Heparin
Study Phase: Phase 3
Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection
Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection
Enrollment Status: Terminated
Publish Date: April 08, 2021
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

164 Total Publications

Randomized, Placebo-Controlled, Triple-Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline-Based Cancer Therapy.
Randomized, Placebo-Controlled, Triple-Blind Clinical Trial of Ivabradine for the Prevention of Cardiac Dysfunction During Anthracycline-Based Cancer Therapy.
Journal: Journal of the American Heart Association
Published: May 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rego's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile